IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells  by Dubois, Sigrid et al.
Immunity, Vol. 17, 537–547, November, 2002, Copyright 2002 by Cell Press
IL-15R Recycles and Presents IL-15
In trans to Neighboring Cells
the trimeric IL-15 receptor (Anderson et al., 1995). In
contrast to IL-2R that displays a low affinity for IL-2
(Kd 10 nM) and is expressed mainly on activated T cells,
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IL-15R has a relatively high affinity for IL-15 (Kd 10–50Center for Cancer Research
pM), and its mRNA has a wide tissue distribution.National Cancer Institute
Consistent with the sharing of IL-2/15c receptorNational Institutes of Health
complex, numerous studies have shown that IL-15 couldBethesda, Maryland 20892
mediate many functions similar to those of IL-2 in vitro
(reviewed in Waldmann and Tagaya, 1999). However,
they also make distinct contributions to the life and theSummary
death of T lymphocytes. Mice that are deficient in their
respective cytokines or their private  chains show dif-We report intriguing aspects of the contribution of IL-
ferent phenotypes. IL-2/ (Kundig et al., 1993) and IL-15R to IL-15 functions. Consistent with high-affinity
2R/ (Willerford et al., 1995) mice develop polyclonalinteractions between IL-15 and IL-15R, these two
T and B cell expansion that is associated with a seriesmolecules form stable complexes on the cell surface
of autoimmune diseases in the IL-2R/ mice. In con-of activated monocytes. The formation of IL-15/IL-
trast, IL-15/ (Kennedy et al., 2000) and IL-15R/15R complexes on cell surfaces induces a trans-
(Lodolce et al., 1998) mice do not manifest lymphoidendosomal recycling of IL-15 leading to the persis-
enlargement or autoimmune disease. Rather, NK cells,tence of surface-bound IL-15 due to the constant
NKT cells, intestinal intraepithelial lymphocytes, andreappearance of IL-15 on plasma membranes. This
CD8 memory T cells are profoundly reduced. Recentcomplex contributes to the long survival of T cells
reports demonstrated that IL-15 and IL-2 also have op-expressing IL-15R after IL-15 withdrawal. Finally,
posing activities when assessed in vivo. The control ofthese complexes on activated monocytes present IL-
homeostasis of memory phenotype CD44hi CD8 T cells15 in trans to target cells such as CD8 T cells that
is supported by IL-15 but is suppressed by IL-2 (Ku etexpress only IL-2/15R and c upon cell-cell inter-
al., 2000). Furthermore, we have previously shown thataction.
IL-15 inhibits the IL-2-mediated activation-induced cell
death (AICD) of CD4 T cells (Marks-Konczalik et al.,Introduction
2000). In summary, these cytokines play distinct roles
in vivo, although significant similarities between IL-15Challenges to the immune system generate responses
and IL-2 have been described in vitro.from both innate and adaptive immunity to engage in-
A series of critical issues remain to be solved concern-vading pathogens. Cytokines play major roles in modu-
ing the role played by IL-15 in the immune response.lating these responses. IL-15, through the activation of
This includes how IL-15 manifests diverse effects on NKeffector functions of NK cells (Carson et al., 1994) and
cells and CD8 T cells despite the fact that virtually nodendritic cells (Ohteki et al., 2001), augments responses
free IL-15 can be measured in biological fluids or theby innate immunity. In addition, IL-15 is pivotal in the
supernatants of activated cells that express a consider-survival of CD8 memory T cells (Ku et al., 2000; Zhang
able amount of IL-15 mRNA. Another critical point is howet al., 1998) and also enhances adaptive immunity during
both cytokines that share the same signal transductionthe immune response.
pathway through the IL-2/IL-15Rc complex can exertIL-15 binds to a specific receptor on T and NK cells.
different functions. The opposing activities of IL-15 and
This receptor consists of three chains, namely IL-15R,
IL-2 in AICD and CD8 memory T cell homeostasis may
, and c molecules. The  and c chains are shared imply possible differences at the level of the signal trans-
between IL-2 and IL-15 and are essential for the signal- duction between these cytokines and may point to a
ing of these cytokines (Giri et al., 1994, 1995). The c possible involvement of the  chains in the signaling of
complex constitutes, on its own, a functional receptor the receptors.
with intermediate affinity for both cytokines that signals In this study, we first focused on the induction of T
through the Jak1/Jak3 and Stat5/Stat3 pathways (John- cell proliferation by IL-15 and IL-2 and assessed the
ston et al., 1995). The IL-15R chain is a private binding contribution of IL-15R to this process. Our data show
molecule specific for IL-15 that has a structural similarity that IL-15 continues to promote cell survival after its
to IL-2R/CD25, its counterpart in the IL-2R system. withdrawal from the media and that this persistent T cell
Both molecules have a similar ligand binding motif (i.e., survival can be explained by an IL-15R-mediated IL-
sushi domain) as well as a relatively short intracellular 15 recycling process that leads to the persistence of IL-
tail (13 aa for human IL-2R, 41 aa for human IL-15R). 15 on the plasma membrane even after its withdrawal
It is widely accepted that the IL-2R chain does not from the environment of the cells. We also demonstrate,
participate in the signal transduction by the IL-2 recep- in contrast to other cytokines, that IL-15 associated with
tor. Likewise, IL-15R may not be involved in the signal IL-15R on one cell stimulates in trans neighboring cells.
transduction by IL-15 in T/NK cells in the context of This effect has a wider biological activity than soluble
IL-15 since the signal induced in trans by the IL-15/
IL-15R complex can stimulate efficiently at picomolar1Correspondence: ytagaya@helix.nih.gov
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Figure 1. Comparison of the Proliferation Induced by IL-2 and IL-15
(A and B) CTLL-2 cells were maintained with IL-2 (500 pM, [A]) or IL-15 (500 pM, [B]) for 3 days. The cells were then starved of cytokine for
4 hr in medium at 37C and stimulated with either IL-2 (black squares), IL-15 (open circles), or media alone (gray bars) for 24 hr. Proliferation
was assessed by 6 hr of [3H]thymidine incorporation.
(C) Apoptosis of CTLL-2 cells was assessed by flow cytometry using propidium iodide/Annexin V-GFP. Cells were first maintained in IL-2
(black bars) or IL-15 (white bars) before cytokine withdrawal.
concentrations the proliferation of both - and IL- 15 receptor. However, Scatchard analysis showed a low
abundance of IL-15R on these cells (100 sites/cells,15R-bearing cells in a similar manner. Finally, we
detect the presence of these biologically active IL-15R/ S.D., unpublished data). We therefore transfected hu-
man IL-15R into CTLL-2 cells (15R-CTLL). MaintenanceIL-15 complexes on the plasma membrane of IL-15-
producing cells, such as LPS/IFN-activated mono- and restimulation by IL-2 showed no significant differ-
ences in the proliferation between these subclones andcytes. Thus, our results collectively reveal a series of
mechanisms that may explain the action of IL-15 in vivo. their parental cells (Figure 2A versus Figure 1A). We
observed that 15R-CTLL had increased sensitivity to IL-
15 after IL-2 withdrawal, possibly caused by the increaseResults
of IL-15R expression. However, if these cells had been
maintained in IL-15, the overexpression of IL-15R ledA Prolonged Effect of IL-15 but Not of IL-2
to a further increase of cell survival after IL-15 with-on the Survival of T Cells after Cytokine
drawal from the media (Figure 2B versus Figure 1B). InWithdrawal from the Media
fact, the proliferation rates remained unaffected for 24In order to compare functions of IL-2 and IL-15 on cellu-
hr by the presence or absence of IL-15 or IL-2. After IL-lar proliferation and survival, we used the murine cyto-
15 withdrawal, the proliferative response became unde-kine-dependent CTLL-2 cell line. Both cytokines in-
tectable after 72 hr (Figure 2C). Moreover, cell prolifera-duced a maximal proliferative response in CTLL-2 cells
tion after IL-15 withdrawal was abrogated by additionat a 50 pM concentration, strongly suggesting the use
of a neutralizing antibody against IL-15 or one directedof high-affinity receptors by both cytokines in these cells
to the  chain but not by one directed against IL-2(Figure 1A). The cells grown with IL-2 (500 pM) lost their
suggesting that the interaction of IL-15 with its receptorproliferative response 24 hr after IL-2 deprivation (shown
plays a role in the persistent IL-15 effect (Figure 2D).by the bar at left). However, following maintenance in
IL-15 (500 pM), we could still detect a strong residual
proliferative response of the cells 24 hr after IL-15 with- Surface-Bound IL-15 Is Associated with
drawal (Figure 1B). Thus, prolonged exposure of CTLL-2 the Expression of IL-15R
cells to IL-15 appeared to modulate the sensitivity of Since our results indicated that the persistence of IL-
these cells to apoptosis induced by cytokine depriva- 15 effects correlated with the increased IL-15R expres-
tion. To examine this effect, we defined the kinetics sion (CTLL-2 versus 15R-CTLL cells), we have hypothe-
of apoptosis following cytokine withdrawal using flow sized that the  chain through its high affinity for IL-15
cytometry (Figure 1C). Consistent with our previous ob- could maintain the cytokine on the cell surface despite
servation, most of the cells had undergone apoptosis IL-15 withdrawal from the media. To test this hypothesis,
within 24 hr after IL-2 withdrawal whereas IL-15 with- we first tried to detect IL-15 on the plasma membrane
drawal resulted in major cell death only after 48 hr depri- of wild-type CTLL-2 and 15R-CTLL cells using an anti-
vation. We concluded that the prolonged exposure to IL-15 antibody by flow cytometry. As shown in Figure
IL-15 of CTLL-2 cells facilitates cell survival after depri- 3A (right panels), when the CTLL-2 cells were incubated
vation of the growth factor. with IL-15 (500 pM) for 15 min at 37C, we were unable
to detect IL-15 on the cell surface, due to the low number
(100 sites) of IL-15R expressed on their surface. How-Contribution of IL-15R in the CTLL-2 Survival
Response to IL-15 ever, after the same treatment, IL-15 was clearly detect-
able on 15R-CTLL cells. It appeared that the degree ofThe response of CTLL-2 cells to picomolar doses of IL-
15 indicated the presence of IL-15R on these cells surface IL-15 staining paralleled the expression of IL-
15R on the cell surface (Figure 3A, left panels). Wesince this chain is indispensable for the high-affinity IL-
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Figure 2. Role of the IL-15R in the Survival of CTLL-2 in Response to IL-15
(A and B) As described above,15R-CTLL was first maintained with either IL-2 (A) or IL-15 (B) and then stimulated with IL-2 (black squares),
IL-15 (open circles), or media alone (gray bars) for 24 hr.
(C) 15R-CTLL cells maintained with IL-15 were tested for their survival without cytokine and followed for up to 72 hr.
(D) Survival of 15R-CTLL cells maintained with IL-15 was examined after 24 hr culture with medium alone and 10 g/ml of anti IL-15, anti-IL-
2R, or anti-IL-2 (control).
observed a similar IL-15 staining when we used 293 induced the slow decrease of surface-bound IL-15 that
paralleled the decline of rates of 15R-CTLL proliferation.cells that were transfected with both IL-15 and IL-15R
(see below), confirming that the  chain alone is suffi- Surface-bound IL-15 was undetectable at the point of
cell cycle arrest that occurred 72 hr after IL-15 depriva-cient to maintain IL-15 on the plasma membrane. We
then examined the kinetics of the decrease of cell-sur- tion (see Figure 2C). Similar results were observed with
the human T cell line Kit-225 transfected with wild-typeface IL-15 on 15R-CTLL cells after its deprivation from
the medium. As shown in Figure 3B, IL-15 withdrawal or an N-terminal FLAG-tagged version of human IL-15R
(15R-Kit and F15R-Kit, see below). These results sug-
gest that the IL-15R expression leads to the continued
presence of IL-15 in association with the plasma mem-
brane even after its withdrawal from the medium and
that this retained IL-15 could cause a prolonged prolifer-
ative response of the cells.
Endosomal Recycling of the IL-15R/IL-15 Complex
In some systems, the receptor engagement can trigger
the internalization of the ligand/receptor complex. Sub-
sequently, the receptor can either be recycled to the
plasma membrane or be degraded. In order to explain
the persistence of IL-15 action following its withdrawal,
we hypothesized that IL-15 can be internalized but can
later recycle back to the plasma membrane of cells that
express IL-15R. Such recycled IL-15 could stimulate
the target cells at later points, which could explain the
prolonged survival effect of IL-15 observed with IL-15R
transfectant cells. To address this question, we removed
the IL-15 from the 15R-CTLL cell surface by acid treat-
ment and followed these cells by flow cytometry to as-
sess the presence of surface-associated IL-15 (Figure
4A). After such stripping by a short treatment with a
glycine buffer (pH 3), cells almost completely lost their
surface-bound IL-15 (Figure 4Ab versus Figure 4Aa).
Following reincubation of cells at 37C in cytokine-free
medium, we observed the reappearance of IL-15 on the
membrane after 24 hr, indicating that internalized IL-15
Figure 3. Surface-Bound IL-15 Associated with IL-15R can be recycled back to the plasma membrane (Figure
(A) (Left panels) Staining of CTLL-2 and 15R-CTLL cells with the 4Ac). To confirm that this process is actually mediated
anti-IL-15R antibody. (Right panels) Staining with the anti-IL-15 by the recycling of IL-15, we investigated the intracellu-
antibody after IL-15 incubation (CTLL-2 and 15R-CTLL cells). lar trafficking of the IL-15/IL-15R complex using sub-
(B) Detection and decay of surface-bound IL-15 on 15R-CTLL cells
cellular fractionation employing a continuous sucroseafter IL-15 maintenance and reincubation with cytokine-free medium
gradient. We transfected Kit-225 with human IL-15Rat 37C for periods up to 72 hr. Dashed line histograms represent
the background staining by isotype controls. with an N-terminal FLAG tag (F15R-Kit) to facilitate the
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Figure 4. IL-15R-Mediated IL-15 Recycling
(A) Detection of surface-bound IL-15 on 15R-CTLL after (a) IL-15 maintenance, (b) IL-15 maintenance then acid stripping (glycine [pH 3.0]) for
10 min to remove bound IL-15, and (c) IL-15 maintenance and acid stripping then reincubation at 37C in a cytokine-free medium for 24 hr,
indicating the reappearance of the IL-15/IL-15R complex on the cell surface.
(B) Control lanes. (Left panel) Lysates from Kit 225 or F15R-kit cells were immunoprecipitated using an anti-FLAG antibody and probed by
the anti-IL-15R antibody. (Right panel) Lysates from F15R-Kit cells were incubated with or without exogenous IL-15 before immunoprecipita-
tion, and detection was performed by anti-IL-15 antibody. This result ruled out the possibility that any non-IL-15 protein from cellular lysates
was detected by the anti-IL-15 antibody.
(C) Subcellular fractionation experiments. F15R-Kit cells after overnight incubation in medium in the absence or presence of IL-15 (500 pM)
were lysed, and the lysates were subinjected onto a continuous sucrose density gradient. Fractions were collected from the top of the gradient
and divided into two parts. After TCA precipitation of one part of each fraction, the distribution of EEA1, biotinylated membrane protein,
Lamp-1, and IL-15 was directly analyzed by immunoblotting (three top panels and last lane). IL-15R and IL-15/IL-15R complex distributions were
assessed on the other part of each fraction by immunoprecipitation with anti-FLAG antibody and probed with anti-IL-15R and anti-IL-15.
specific and efficient immunoprecipitation of IL-15R ing anti-IL-15R and anti-IL-15 antibodies. As shown in
Figure 4C, fractions 6 and 7 predominantly contained(Figure 4B). These IL-15R cells were maintained in
IL-2 and subsequently incubated overnight at 37C in the early endosomes that were characterized by early endo-
some antigen 1 (EEA1). Biotinylated membrane proteinspresence or absence of IL-15. We biotinylated surface
proteins in order to trace the plasma membrane compo- were found in fractions 8–10. The plasma membrane
proteins were also detected in fraction 2 and sometimesnents. Following ultracentrifugation we arbitrarily sepa-
rated the gradient into 12 fractions of equal volume. 3 possibly due to the damage of the membrane during
cell lysis. The lysosomal fractions characterized by lyso-A part of each fraction was directly analyzed for the
presence of indicator proteins for particular organelles, somal-associated membrane protein 1 (Lamp 1) were
found in fractions 9 and 10 partially overlapping with thewhile the remaining part was immunoprecipitated using
an anti-FLAG antibody, followed by immunoblotting us- plasma membrane. When F15R-Kit cells were cultured
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without IL-15, the immunoprecipitated IL-15R was the absence of the  chain, indicating that the  chain
is not required for the IL-15 recycling.found associated with the plasma membrane and the
lysosomal compartments (fractions 8–10, Figure 4C). In
contrast, the culture of F15R-Kit with IL-15 was associ- The IL-15R/IL-15 Complex Stimulates Proliferation
ated with the appearance of IL-15R in the endosomal of Neighboring Cells In trans
fractions (fractions 6 and 7), supporting the view that Although IL-15 has vital effects, it is virtually undetect-
IL-15 induces the internalization of IL-15R. IL-15 that able in vivo in biological fluids. Therefore, the sources
coimmunoprecipitated with IL-15R was also localized and characteristics of this cytokine action remain un-
to the endosomes (fraction 7) and plasma membrane clear. As the IL-15 recycling led to the persistence of
compartments (fraction 7 and 8) as well as in fraction the cytokine on the plasma membrane, we investigated
9. The same distribution pattern of IL-15 was observed whether the membrane IL-15/IL-15R complex is bio-
when the samples were analyzed without immunopre- logically active in trans. In particular, we asked if this
cipitation, suggesting a strong and stable interaction complex could stimulate neighboring cells into prolifera-
between IL-15 and IL-15R even after internalization, tion in trans. We mixed wild-type CTLL-2 cells with dif-
which gives rise to the recycling of the IL-15/IL-15R ferent numbers of 15R-Kit cells that had been incubated
complex. The proportions of IL-15R/IL-15 complexes with IL-15, starved overnight, and then fixed with 2%
found in early endosome and plasma membrane com- paraformaldehyde. We then followed the proliferative
partments were similar after short (20 min or 2 hr) and response of CTLL-2 cells by [3H]thymidine incorporation.
long (15 hr) exposures to IL-15 (data not shown). In As controls, 15R-Kit cells preincubated with IL-2 and
summary, these results show the appearance of the wild-type Kit-225 cells preincubated with IL-15 were in-
IL-15/IL-15R complex in the endosomes after IL-15 cluded. As shown in Figure 6A, only the cells expressing
stimulation, supporting the hypothesis that IL-15 can be IL-15R and preincubated with IL-15 stimulated CTLL-2
recycled by a process that involves its interaction with proliferation. This response was observed until the ratio
IL-15R and the reappearance of the IL-15/IL-15R of the two cells dropped to 1:1. The low thymidine uptake
complex on the cell surface. observed at the ratio 100:1 could possibly be due to
the high cellular concentration per well that could have
caused toxicity. As these data showed that IL-15 pre-IL-15 Recycling Depends on IL-15R
but Not on the  Chain sented by IL-15Rwas biologically active, we examined
the nature of the receptors on adjacent cells that wereTo date, there is no widely accepted role for the cyto-
plasmic portion of IL-15R in the context of the function engaged in this process of trans-proliferation. In particu-
lar, we wanted to know if the  trimer IL-15 receptorof the trimeric receptor (). Indeed, the IL-15 prolifera-
tive responses of cells, which express the  and the  was needed for this process. We therefore used PT-18
cells that express  and  chains but not the IL-15Rchains and which had been transfected by either full-
length or a version lacking the cytoplasmic domain of chain. Interestingly, we observed that surface-bound IL-
15 presented by 15R-Kit induced the proliferation ofIL-15R, were similar (Anderson et al., 1995). Neverthe-
less, we speculated that the cytoplasmic domain of IL- PT-18 cells in a similar dose-dependent manner as
observed with CTLL-2 cells (Figure 6B), indicating that15R might contribute to the IL-15 recycling phenome-
non. We transfected Kit-225 cells with a deletion mutant the IL-15/IL-15R complex can stimulate adjacent cells
in trans through the expression of only the intermediateof hIL-15R (	Cterm15R-Kit) lacking most (38 of the 41
aa) of the cytoplasmic domain and compared the IL- affinity receptor complex  by these responder cells.
We then evaluated the contribution of the IL-15R ele-15 recycling process between 	Cterm15R- and 15R-Kit
(expressing the full-length IL-15R) cells. As shown in ment in the IL-15/IL-15R complex in this trans-prolifer-
ation process. To address this question, we comparedFigure 5A, both cell lines expressed a similar density of
IL-15R on the plasma membrane and bound similar the proliferation of  and IL-15R-bearing cells (PT-
18 and 15R-PT-18) in their response to IL-15 in theamounts of IL-15 as demonstrated by flow cytometry.
However, after acid treatment and reincubation in cyto- absence or presence of irradiated nonproliferating IL-
15R-expressing cells (15R-PT-18) or of PT-18 cellskine-free medium, we observed the reappearance of IL-
15 only with 15R-Kit cells that retained the cytoplasmic which were used as controls. As expected, PT-18 cells
responded to a subnanomolar dose of soluble IL-15,domain. The proliferation experiments confirmed these
data since only 15R-Kit cells but not 	Cterm15R-Kit corresponding to the intermediate affinity of the  re-
ceptor that they express (Figure 6C). In contrast, wecells manifested cell survival following IL-15 withdrawal
(Figure 5B). Thus, our results suggest that the cyto- observed that the coculture of these cells with irradiated
15R-PT-18 cells allowed a significant increase of theplasmic domain of IL-15R plays an essential role in
IL-15/IL-15R complex recycling. Next, to examine the sensitivity of PT-18 cells to picomolar concentrations
of IL-15, indicating that the presentation of IL-15 by IL-contribution of the  chain to the recycling process, we
used a mast cell line PT-18 that expresses the  chain 15R enabled -expressing cells to respond to the
low physiological doses of IL-15. In accord with theirbut not the  or IL-15R molecules (Tagaya et al., 1996).
After establishing PT-18 subclones expressing human expression of high-affinity receptor complexes, 15R-PT-
18 cells responded to picomolar concentrations of sol-IL-15R (15R-PT-18) or both IL-15R and  chains (15R-
PT-18), we compared the IL-15 recycling process as uble IL-15 (Figure 6D). In this case, the coculture experi-
ments with irradiated 15R-PT-18 provoked a decreasedescribed above using flow cytometry. PT-18 express-
ing IL-15R could recycle IL-15 (Figure 5C). Further- of the response to IL-15 that nevertheless was still in
the picomolar range and similar to the PT-18 responsemore, no difference was observed in the presence or
Immunity
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Figure 5. IL-15R-Mediated IL-15 Recycling Requires the Expression of the Cytoplasmic Tail of IL-15R but Not the  Chain
(A) Detection of IL-15R (left panels) and IL-15 (middle and right panels) on 15R-Kit and 	Cterm-15R-Kit was assessed by flow cytometry.
Surface-bound IL-15 was measured after IL-15 binding (middle panels), and then cells were stripped by acid treatment and incubated in
cytokine-free media for 24 hr to induce the reappearance of surface-bound IL-15 (right panels).
(B) Evaluation of the [3H]thymidine uptake of the two forms of 15R-Kit (top) and 	Cterm-15R-Kit (bottom) cells cultured in cytokine-free medium
for 24 hr after IL-2 1 nM or IL-15 1 nM culture.
(C) Detection of surface-bound IL-15 on 15R-PT-18 and 15R-PT-18 cells before and after acid treatment. To compare these cells in their
capacity to recycle IL-15, cells were further reincubated for 24 hr in cytokine-free medium following the acid treatment.
in coculture with irradiated 15R-PT-18 cells. The IL-15 be the cause of the decrease in the proliferative re-
sponse observed in the coculture. Taken together, ourrecycling process and a possible competition between
the two IL-15R-expressing cells for soluble IL-15 might data suggest that the interaction between IL-15 and IL-
15R leads to the formation of a biologically active IL-
15R/IL-15 complex that in trans can interact with 
complex on adjacent cells to deliver an efficient and
comparable signal to either - or IL-15R-bearing
cells.
IL-15R/IL-15 Complexes on the Surface of Activated
Monocytes Induce trans-Proliferation of -
Expressing Neighboring Cells
Several studies have already described the existence of
a membrane form of IL-15 after activation of monocytes
with LPS, IFN and with GM-CSF as well (Musso et al.,
1999; Neely et al., 2001). This membrane form of IL-
15 was biologically active inducing T cell proliferation.
However, how IL-15 was anchored onto the plasma
membrane remained unknown. In parallel, our labora-
tory previously showed that both IL-15 (Bamford et al.,
1996) and IL-15R (Mariner et al., 2002) transcripts were
coordinately upregulated in monocytes by LPS and IFN
stimulation. In light of this observation, we attempted
to determine whether the coexpression of IL-15 and IL-
15R by activated monocytes resulted in the appear-
ance of surface-bound IL-15 on these cells. To address
this question, human elutriated monocytes were stimu-
lated with LPS and IFN for 24 hr. The availability of a
new monoclonal anti-IL-15R antibody generated in our
group allowed us to measure the membrane expression
of both IL-15 and IL-15R directly by flow cytometry.Figure 6. trans-Proliferation Effect of the IL-15/IL-15R Complex
We detected neither IL-15 nor IL-15R on resting mono-Expressed by One Cell on Neighboring Cells
cytes. In contrast, stimulated monocytes displayed sig-(A) 15R-Kit cells were first maintained with IL-15 (500 pM) for 24 hr,
starved for 24 hr, fixed, and then incubated with CTLL-2 cells. Kit- nificant levels of both IL-15 and IL-15R on their sur-
225 cells maintained with IL-15 and 15R-Kit maintained with IL-2 faces (Figure 7A). The acid treatment of these cells
were used as controls. resulted in the dissociation of IL-15 from the plasma
(B) As described in (A), fixed 15R-Kit cells from IL-15 cultures were membrane without affecting the IL-15R expression.
incubated with PT-18 and PT-18 cells.
The incubation of these cells after acid treatment at 37C(C and D) PT-18 (C) and 15R-PT-18 (D) cells were incubated with
for 15 min with exogenous IL-15 restored the stainingIL-15 alone or with irradiated 15R-PT-18 or with PT-18 cells. The
proliferations were assessed by 6 hr of [3H]thymidine incorporation. almost to the level that had been obtained before acid
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Figure 7. The Coexpression of IL-15 and IL-
15R and trans-Proliferation Effect Mediated
by Activated Monocytes
Elutriated human monocytes were first stimu-
lated with or without IFN (10 ng/ml) and LPS
(1g/ml) for 24 hr.
(A) Detection of IL-15 and of IL-15R on the
plasma membranes of resting and stimulated
monocytes by flow cytometry before and
after acid treatment and following reincuba-
tion with IL-15 (500 pM) for 15 min at 37C
(dashed lines 
 isotype controls).
(B) PT-18 or 15R-PT-18 cells were mixed
either with resting (RM) or stimulated mono-
cytes (SM) that were previously fixed or with
the culture supernatants of monocytes that
were stimulated for 24 hr. Ten g/ml of neu-
tralizing anti-IL-15 or anti-IL-2 (used as a con-
trol) was added as indicated. The prolifera-
tions were assessed by 6 hr of [3H]thymidine
incorporation.
(C) 293 cells were transfected with IL-15 alone
or combined with IL-15R. The cotransfec-
tion of IL-15 with the  chain or IL-2R were
used as controls. The amount of IL-15 in the
medium was measured by a specific ELISA
(R&D systems) 24 hr after transfection. Sur-
face-bound IL-15 was detected by flow cy-
tometry as described above.
treatment, confirming that the staining observed after Discussion
activation was IL-15 specific. These results demonstrate
In this report we present mechanisms for IL-15 actionthat the IL-15 expressed by activated monocytes is not
that are initiated and dependent on the formation of adirectly anchored onto the plasma membrane but rather
stable complex between IL-15 and IL-15R. Previoussuggest that the cytokine binds to IL-15R. We then
reports described the cellular trafficking of IL-15R, in-compared the capacity of this surface-bound IL-15 to
cluding its potential nuclear translocation (Dubois et al.,induce in trans the proliferation of cells bearing  or
1999; Pereno et al., 1999). Here, we show that IL-15RIL-15R complex. PT-18 or 15R-PT-18 cells were
mediates a trans-endosomal recycling of IL-15, therebycocultured with resting or activated monocytes that had
leading to the persistence of IL-15 signaling even afterbeen fixed with 2% paraformaldehyde (Figure 7B). The
withdrawal of the cytokine from the media. In addition,culture supernatants of activated monocytes did not
we demonstrated that IL-15R presents IL-15 in transmanifest any proliferative activity indicating that the IL-
to neighboring cells, thus enabling these intermediate-15 was not secreted. Only activated monocytes per se
affinity IL-15R/c complex-expressing cells to respondwere able to support the proliferation of both cell lines.
to a 100 pM concentration of IL-15.Moreover, this proliferative response was specifically
We observed that the T cell line CTLL-2 survivedinhibited by the addition of an anti-IL-15 neutralizing
longer after withdrawal of IL-15 than of IL-2 and that thisantibody, demonstrating that the surface-bound IL-15
expressed by activated monocytes was biologically ac- difference is further enhanced by the overexpression of
IL-15R. Moreover, cells grown in both IL-2 and IL-15tive. According to our data presented above, the similar-
ity of the proliferative rates between PT-18 and 15R- displayed similar proliferation kinetics after cytokine
withdrawal to that observed with IL-15 alone (data notPT-18 cells supports the idea that IL-15 found on the
membrane of activated monocytes is maintained by IL- shown). We showed that the time course of cell survival
after IL-15 withdrawal correlated with the levels of recy-15R in an IL-15/IL-15R complex. To support the idea
that a cell expressing both IL-15 and IL-15R can pres- cled IL-15 detectable on the plasma membrane. The
addition of neutralizing anti-IL-15 antibodies abrogatedent the cytokine on the plasma membrane in association
with the  chain, we examined the proportion of soluble this cell survival. These results suggest that the persis-
tence of recycled IL-15 associated with IL-15R on theand surface-bound IL-15 when both IL-15 and IL-15R
were transfected into 293 cells. The cotransfections of plasma membrane underlies the persistent cell survival
after cytokine withdrawal. The possible competition be-IL-15 with the  chain or IL-2R were used as controls.
As shown in Figure 7C, only the cotransfection of IL-15 tween IL-15 and IL-2 for  complexes does not appear
to interfere with IL-15 recycling, confirming that thisand IL-15R led to a decrease of IL-15 expression in the
media and to the surface expression of IL-15, suggesting process does not require the expression of the  and 
subunits. Thus, the difference between IL-2 and IL-15that IL-15 and IL-15R expressed by the same cell ap-
pear preferentially to exist as a complex on the plasma in this model probably results from the distinct endocy-
tosis pathways of both cytokines that are in large mea-membrane.
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sure determined by their affinity for their private receptor IL-2 onto the plasma membrane (Fallon et al., 2000).
Second, the  subunits appear to be required only for subunits (see below).
A challenge was the elucidation of the biochemical the trafficking of IL-2R since the recycling of IL-15
occurs in cells that are negative for the  chain. Theseevents underlying our observations on the recycling and
reappearance of the IL-15/IL-15R complex on the cell two differences, the affinity of ligand/receptor interac-
tion and the requirement for the  chain, could be thesurface. A common event following the receptor en-
gagement in many systems is the internalization of the basis for the distinct fates of IL-2 and IL-15 after internal-
ization.ligand/receptor complex. IL-15R appears to belong to
this category of receptors since IL-15 addition to IL- Studies of mice deficient in IL-15 or IL-15R revealed
that the survival of memory CD8 T cells appears to be15R-expressing cells leads to the appearance of the
 chain in the early endosomal compartment. After en- dependent on IL-15 by providing an essential signal for
a slow but constant cell division (Ku et al., 2000). As IL-15docytosis, many ligand/receptor complexes are trans-
ported to late endosomal compartments to be degraded is undetectable with the present methods in biological
fluids, a critical unsolved issue was how an extremelyin the lysosomes (Mukherjee et al., 1997). Receptors,
such as the transferrin receptor, release their ligand low abundance of this cytokine can maintain memory T
cells that constantly migrate through peripheral tissuesinto the low pH environment of early endosomes before
recycling back to the plasma membrane (Klausner et (Sallusto and Lanzavecchia, 2000). Our results may pro-
vide an explanation for this paradox. In particular weal., 1983). Consistent with the high-affinity interaction
between IL-15 and IL-15R, we could coimmunoprecipi- indicated that the IL-15 recycling process allows CTLL-2
cells to survive for more than 24 hr after cytokine with-tate both molecules from different cellular compart-
ments suggesting that these molecules stay tightly as- drawal. Even if the regulation of IL-15R expression by
memory CD8 T cells is not clearly elucidated, it appearssociated after internalization and follow the same
intracellular trafficking route. IL-15R does not appear that some of these cells can express the  chain (Azimi
et al., 2001). In this case, IL-15R- mediated IL-15 recy-to be actively targeted to the degradation pathway by
interaction with IL-15 since we did not detect differences cling may provide a mechanism that supports the long-
term survival of CD8 memory T cells, despite an infre-in the lysosomal distribution of IL-15R in the absence
or presence of IL-15. In contrast, we found a persistence quent stimulation of these cells by IL-15.
The persistence of recycled IL-15 on the cell surfacein early endosomes of the IL-15/IL-15R complexes that
remains essentially unchanged even after several hours in association with IL-15R prompted us to investigate
whether this cytokine reservoir might stimulate theof IL-15 stimulation. Concordant with this view, we ob-
served the reappearance of IL-15 bound to IL-15R on neighboring cells. We demonstrated that IL-15 main-
tained by IL-15R on the plasma membrane could bethe plasma membrane with all IL-15R transfected cell
lines studied. In conclusion, the IL-15/IL-15R com- presented to either IL-15R- or -bearing cells to
induce their proliferation. We showed that IL-15R par-plexes appear to be recycled between the plasma mem-
brane and endosomes rather than being targeted for ticipates directly in this trans-proliferation process by
increasing the affinity of IL-15 for the  complex thatdegradation in the lysosomes.
Protein motifs that mediate recycling remain largely is expressed on the adjacent cell. The IL-15/IL-15R
complex appears to display a wider biological activityunknown. It has been suggested that recycling occurs
by default (Gruenberg and Kreis, 1995; Gruenberg and than the soluble IL-15 since it can efficiently stimulate
the proliferation of - and IL-15R-bearing cells inMaxfield, 1995). Removal of either the cytoplasmic or
extracellular domain of the transferrin receptor had no a similar manner. Therefore, it is conceivable that the
cells bearing the two types of receptor (high and inter-effect on its recycling (Jing et al., 1990; Johnson et al.,
1993). However, in our study we show that the IL-15R mediate affinity) can be stimulated in vivo despite a low
level of cytokine.cytoplasmic domain appears to be crucial for the recy-
cling process since its deletion abrogated IL-15 recy- Monocytes are a main source of IL-15 in vivo (Bamford
et al., 1996; Carson et al., 1994). These cells constitu-cling. The identity of a putative specific recognition motif
in IL-15R needs to be elucidated. tively express IL-15 mRNA, which can be further upregu-
lated by stimulation with IFN, LPS, and GM-CSFThe binding of IL-2 has been demonstrated to induce
the internalization of the IL-2R receptor complex. (Musso et al., 1999; Neely et al., 2001). Following such
stimulation, however, IL-15 is not secreted but can beWhereas the cytokine together with the  and  chains
are targeted for lysosomal degradation, IL-2R is re- detectable in association with the plasma membrane.
Do monocytes coexpress IL-15 and IL-15R to formleased from the receptor complex and relocates to the
plasma membrane. The IL-2R recycling is not only de- cell-surface IL-15/IL-15R complexes? The promoter
regions of these two genes share critical transcriptionalpendent on IL-2 binding but also requires the presence
of the  complex (Hemar et al., 1995). Various aspects motifs, one NFB site, and two Interferon regulatory
elements (IREs) (Azimi et al., 2001; Mariner et al., 2002).of the recycling process appear to be similar for IL-
2R and IL-15R. Nevertheless, two major differences Therefore, a common stimulation may potentially induce
both molecules in the same cell. Indeed, we demon-contribute to the distinctions between these cytokines
and their receptors. First, the IL-15/IL-15R association strated in this study that this occurs in monocytes, re-
sulting in the formation of an IL-15/IL-15R complex onis much more stable than that of IL-2 with IL-2R. In our
hands, the dissociation of the IL-15/IL-15R complexes the monocyte surface. As IL-15 can be released follow-
ing acid treatment of the cells, the cytokine seems to beoccurs only at pH 3.0. Consistently, increasing the IL-
2/IL-2R affinity by using an IL-2 mutant prevented their noncovalently attached to the surface via its interaction
with IL-15R. The discrepancy in this regard with a previ-lysosomal degradation and led to a reappearance of
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ous report by Musso et al. may be explained by their use cells in the IL-15R/ mouse. We propose that one of
of a pH 4.4 buffer, which in our hands was insufficient the main functions of IL-15R may be the generation of
to dissociate the IL-15/IL-15R complex (Musso et al., an IL-15 reservoir. On the one hand, if a memory CD8
1999). Surface-bound IL-15 presented by activated T cell expresses the  chain, IL-15R binds and recycles
monocytes induced the proliferation of cells that ex- IL-15 that then stored can support the long-term survival
press either IL-15R or  alone in a similar fashion. of the cells. On the other hand, we also propose that
Consistent with our data described above, these find- the cells expressing the  chain can be different from
ings reinforce the idea that the surface-bound IL-15 on those bearing the  complex. Interestingly, the produc-
activated monocytes is associated with IL-15R. Paral- tion and expression of IL-15 and IL-15R seems to over-
lel to that, our preliminary data suggest that the IL-15/ lap, enabling the formation of an IL-15/IL-15R complex
IL-15R complexes may exist on others cells such as on the surface of cells such as monocytes, dendritic,
dendritic cells and stromal cells that express both gene and stromal cells. Furthermore, this complex in turn can
products (S.D. and Y.T., unpublished data). be trans-presented to neighboring cells, which express
Cellular contacts play an important role in the stimula- intermediate-affinity IL-15R.
tion of T cells by antigen-presenting cells (APCs) includ-
Experimental Proceduresing monocytes. It is conceivable that the presentation
of IL-15 by IL-15Ron the membrane of activated mono-
Cell Lines and Reagentscytes may be an important mechanism that allows the
CTLL-2 and 293 cells were obtained from American Type Culture
survival and proliferation of CD8 T cells expressing Collection. Kit-225 (Grant et al., 1992) and PT-18 (Tagaya et al.,
high levels of the  complexes. Our view of trans- 1996) were used as described previously. Elutriated monocytes were
activation of T cells by IL-15 expressed on the surface prepared by the Blood Bank (NCI, NIH Bethesda). Human rIL-2 was
a gift from Hoffmann LaRoche, and human rIL-15 was purchasedof monocytes and dendritic cells may provide a new
from Peprotech. Mouse anti-human IL-15 and IL-2 were purchasedinterpretation of an interesting observation recently re-
from R&D Systems, mouse anti-human Lamp-1 and EEA-1 fromported by Lodolce and coworkers (Lodolce et al., 2001).
Transduction Laboratories, and rabbit (H-107) and goat (C20) anti-This work showed that normal CD8 T cells transferred
human IL-15R from Santa Cruz Biotechnology. The secondary anti-
into IL-15R/ mice lost their proliferative response bodies used for flow cytometry and rat anti-murine  were pur-
whereas IL-15R/CD8T cells proliferated in a normal chased from PharMingen, and the secondary antibodies used for
host environment. The authors suggested that there Western blot were from Amersham.
might be a feedback regulation of IL-15 production me-
Construction and Transfectiondiated by the IL-15R. While this possibility needs to
IL-15, IL-2R, and IL-2R plasmids were made in our laboratorybe explored, we suggest an alternative explanation. If
(Tagaya et al., 1996, 1997). The cDNA encoding for IL-15R wasthe CD8 T cells require presentation of membrane IL-15
PCR amplified. The primers pairs used were: 5-ACGCGTATCACGT
by monocyte/dendritic or stromal cells (environmental GCCCTCCCCCCATGTCC and 5-GGATCCTCATAGGTGGTGAGAG
cells), the loss of IL-15R from these environmental cells CAGTTTTC for the full-length version, 5-ACGCGTGACTATAAGGAT
in the IL-15R/ host will render these cells unable to GACGATGACAAGATCACGTGCCCTCCCCCCATGTCC and 5-GGA
TCCTCATAGGTGGTGAGAGCAGTTTTC for the FLAG-tagged ver-present IL-15 to CD8 T cells. In contrast, environmental
sion, and 5-ACGCGTATCACGTGCCCTCCCCCCATGTCC and 5-cells from normal mice can efficiently present IL-15 to
GGATCCTCATGACTTGAGGTAGCATGC for the version lacking aCD8 T cells even if the T cells do not express IL-15R,
cytoplasmic tail. All fragments were subcloned into pEF-Neo vector
as we have demonstrated in this study. containing the signal peptide of bovine preprolactin (Tagaya et al.,
Because of the high-affinity nature of the binding be- 1997). Stable transfections of CTLL-2, Kit-225, and PT-18 cells were
tween IL-15R and IL-15, this cytokine appears to exist performed by electroporation. 293 cells were transfected with Lipo-
fectamine 2000 (Invitrogen), according to the manufacturer’s in-mainly associated with the  chain rather than being
structions.soluble. Our study revealed that in addition to the soluble
IL-15 the stable IL-15/IL-15R complex can have a cru-
Monoclonal Antibody Productioncial role in vivo since this appears to enhance the persis-
The entire extracellular portion of human IL-15R was expressedtency of IL-15 signaling. The membrane bound and per-
as a GST-fusion protein (pGEX-2T, Pharmacia) in E. coli to immunize
sistent nature of IL-15 signaling contrasts with that of mice. The fusion process was performed according to the standard
soluble IL-2 and the noncell bound nature of IL-2 signal- operating procedures of Cocalico Inc. Laboratories. The screening
ing. This difference may account for the fundamental of the antibody was performed by flow cytometry to select clones
reacting with IL-15R-positive cells. This antibody (clone 7A4,functional differences observed between these two cy-
mouse IgG2b) was tested extensively with human IL-15R and IL-tokines in vivo. Furthermore, it suggests that IL-15 sig-
15R cell lines. 293/COS cells were negative but became positivenaling primarily occurs in the context of cell-cell contact
after transfection with human IL-15R cDNA. The antibody did notand that the IL-15 signal associates at most if not at all block IL-15-mediated proliferation of CTLL-2 cells (data not shown).
times with other signals to the T cell originating from
CD40/CD40L, TCR-antigen-MHC, and CD28/CD86 in- Flow Cytometry, Proliferation, and Apoptosis
teractions. Thus, IL-2 mediates its signal through the  All these procedures were performed as described previously
(Marks-Konczalik et al., 2000). For acid treatment, the cells wereand  receptors alone whereas IL-15 provides these
incubated in ice-cold glycine buffer (25 mM glycine, 150 mM NaClsame signals but now modified by the expressed signals
[pH 3]) for 10 min.coordinately provided by the other cell receptor-counter
receptors of the interacting APCs and T cells.
Cellular Fractionation
In summary, the three molecules comprising the IL- F15R-Kit cells (1  108) were incubated with or without IL-15 (500
15R, namely the , , and  should work together to pM) overnight, washed twice with PBS and resuspended in 30 ml
make IL-15 an active cytokine in vivo, as is demon- of ice-cold buffer (0.1 M Na2PO4 [pH 7.2]), and then incubated with
1.5 mg biotin (Sigma) on ice for 30 min. The cells were then resus-strated by the disappearance of CD8 T cells and NK
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pended in 1 ml of buffer (25 mM HEPES, 25 mM sucrose, 50 mM T lymphocytes: distinct intracellular localization and fate of the re-
ceptor , , and  chains. J. Cell Biol. 129, 55–64.KCl, 1mM EGTA, and 1mM EDTA [pH 7.4]) and protease inhibitor
cocktail (Roche) for 15 min incubation on ice. Then the lysates were Jing, S.Q., Spencer, T., Miller, K., Hopkins, C., and Trowbridge, I.S.
passed through a 26G needle and centrifuged at 800 g for 10 min. (1990). Role of the human transferrin receptor cytoplasmic domain
The postnuclear supernatant was placed on top of a continuous in endocytosis: localization of a specific signal sequence for internal-
sucrose gradient (10%–60%) and centrifuged at 38,000 rpm for 16 ization. J. Cell Biol. 110, 283–294.
hr at 4C. The gradient was collected by 1 ml fraction from the top.
Johnson, L.S., Dunn, K.W., Pytowski, B., and McGraw, T.E. (1993).The half of each fraction was immunoprecipitated with anti-FLAG
Endosome acidification and receptor trafficking: bafilomycin A1antibody. The other part was precipitated with 10% trichloroacetic
slows receptor externalization by a mechanism involving the recep-acid (TCA) and directly subjected to immunoblotting.
tor’s internalization motif. Mol. Biol. Cell 4, 1251–1266.
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